Abhay HealthTech has announced the expansion of its product portfolio to support India’s shift toward consumer-controlled and preventive healthcare. The company’s offerings now include rapid diagnostic kits, hygiene products, wellness goods, and telehealth services—responding to growing demand for home-based medical solutions.
This move aligns with broader market trends. India’s over-the-counter (OTC) drug segment is currently valued at approximately USD 6.7 billion in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.4 per cent through 2033. Similarly, the home healthcare market, valued at USD 5.7 billion in 2024, is expected to reach over USD 11.6 billion by 2030, growing at nearly 13 per cent CAGR.
The demand for at-home testing continues to rise. India’s rapid test kit market was valued at USD 403 million in 2024 and is expected to reach USD 605 million by 2030, with a CAGR of 6.8 per cent. OTC pain relief, a key component of self-care, has reached ₹16,000 crore (approximately USD 2 billion) by mid-2025, showing strong consumer preference for quick and convenient health solutions. At the same time, the adoption of home-use medical devices is increasing. With hypertension prevalence rising, blood pressure monitor penetration—currently at around 6 per cent—is expected to grow significantly.
Abhay HealthTech’s Assure and ActFast product lines offer rapid, lab-accurate results suitable for use at home, in clinics, or in remote areas. The company adheres to ISO-certified manufacturing standards and claims clinically validated diagnostic accuracy exceeding 99 per cent.
The company’s portfolio also spans OTC wellness categories, including hygiene, skincare, women’s health, and baby care. It is supported by an advisory board comprising former leaders from companies such as Reckitt, Johnson & Johnson, and Columbia Asia.
“Innovation isn’t just about something new; it’s about something that truly matters. We bridge the gap between traditional care and modern convenience so people can take control of their health at home,” said Apurv Modi, Managing Director of Abhay HealthTech.
With India investing approximately 2.1 per cent of its GDP in healthcare and a growing middle class looking for affordable care, Abhay HealthTech aims to address a key gap. Its healthtech-enabled ecosystem delivers diagnostic tools, preventive products, hospital consulting, and telehealth solutions tailored for households, clinics, and local communities.